V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20022587 | 20009596 | 1.54 | 68 | Adjuvant (A) | 2014-12-08 | 2014-12-08 | FEC + DOCETAXEL | 02 | N | 20079571 | FEC + DOCETAXEL |
| 20022588 | 20009596 | 1.55 | 83.3 | Adjuvant (A) | 2017-04-28 | 2017-05-03 | FEC 100 + DOCETAXEL | 02 | N | 20079571 | FEC + DOCETAXEL |
| 20022589 | 20009597 | 1.53 | 69 | Adjuvant (A) | 2017-09-17 | 2017-09-22 | FEC + DOCETAXEL | 02 | N | 20079584 | FEC + DOCETAXEL |
| 20022590 | 20009597 | 1.7 | null | Neo-adjuvant (N) | null | 2013-07-07 | FEC 100 + DOCETAXEL | null | null | 20079584 | FEC + DOCETAXEL |
| 20022591 | 20009598 | null | 85.8 | Neo-adjuvant (N) | 2014-09-09 | 2014-09-27 | FEC + DOCETAXEL | N | N | 20079587 | FEC + DOCETAXEL |
| 20022592 | 20009598 | 1.7 | 74.9 | Palliative (P) | 2015-04-16 | 2015-04-16 | FEC + DOCETAXEL | 02 | N | 20079587 | FEC + DOCETAXEL |
| 20022593 | 20009599 | 1.66 | 69.2 | Adjuvant (A) | null | 2013-10-02 | FEC + DOCETAXEL | N | N | 20079597 | FEC + DOCETAXEL |
| 20022594 | 20009599 | 1.53 | null | Adjuvant (A) | 2014-05-25 | 2014-06-06 | FEC + DOCETAXEL | N | null | 20079597 | FEC + DOCETAXEL |
| 20022595 | 20108200 | null | null | Adjuvant (A) | 2015-08-24 | 2015-09-04 | FEC 100 + DOCETAXEL | N | null | 20079607 | FEC + DOCETAXEL |
| 20022596 | 20009600 | 1.46 | 81 | Adjuvant (A) | 2013-05-29 | 2013-06-14 | FEC 100 + DOCETAXEL | 2 | N | 20079615 | FEC + DOCETAXEL |
| 20022597 | 20009600 | 1.65 | 74 | Adjuvant (A) | 2013-07-15 | 2013-07-16 | FEC + DOCETAXEL | 02 | N | 20079615 | FEC + DOCETAXEL |
| 20022598 | 20009601 | 1.55 | 81 | Adjuvant (A) | 2018-02-16 | 2018-02-25 | FEC + DOCETAXEL | N | N | 20079632 | FEC + DOCETAXEL |
| 20022599 | 20009601 | 1.7 | 96.8 | Adjuvant (A) | 2014-06-19 | 2014-06-19 | FEC + DOCETAXEL | 02 | Y | 20079632 | FEC + DOCETAXEL |
| 20022600 | 20009601 | 1.63 | 80.5 | Neo-adjuvant (N) | 2013-02-11 | 2013-02-24 | FEC + DOCETAXEL | 02 | Y | 20079632 | FEC + DOCETAXEL |
| 20022601 | 20009602 | 1.65 | 54.3 | Curative (C) | 2017-09-05 | 2017-09-12 | FEC + DOCETAXEL | 02 | N | 20079636 | FEC + DOCETAXEL |
| 20022602 | 20009602 | 1.66 | 62.2 | Not known (9) | 2017-02-09 | 2017-02-13 | FEC + DOCETAXEL | 02 | N | 20079636 | FEC + DOCETAXEL |
| 20022603 | 20009602 | 1.64 | 83.9 | Neo-adjuvant (N) | 2017-12-08 | 2017-12-15 | FEC + DOCETAXEL | 2 | N | 20079636 | FEC + DOCETAXEL |
| 20022604 | 20009602 | 1.63 | 66 | Adjuvant (A) | 2016-04-01 | 2016-04-01 | FEC + DOCETAXEL | 02 | N | 20079636 | FEC + DOCETAXEL |
| 20022605 | 20009602 | 1.68 | 80 | Adjuvant (A) | 2014-09-27 | 2014-10-11 | FEC 100 + DOCETAXEL | N | N | 20079636 | FEC + DOCETAXEL |
| 20022606 | 20009602 | null | 60.1 | Not known (9) | 2015-01-16 | 2015-01-22 | FEC 100 + DOCETAXEL | 02 | N | 20079636 | FEC + DOCETAXEL |
| 20022607 | 20009603 | 1.74 | 79 | Adjuvant (A) | 2015-01-17 | 2015-01-19 | FEC + DOCETAXEL | 2 | N | 20079661 | FEC + DOCETAXEL |
| 20022608 | 20009603 | 1.52 | 65.5 | Curative (C) | 2014-06-16 | 2014-06-30 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20079661 | FEC + DOCETAXEL |
| 20022609 | 20009603 | 1.63 | 69.6 | Adjuvant (A) | 2016-01-24 | 2016-01-30 | FEC + DOCETAXEL | 2 | N | 20079661 | FEC + DOCETAXEL |
| 20022610 | 20009604 | 1.63 | 44.6 | Adjuvant (A) | 2015-01-14 | 2015-01-27 | FEC 100 + DOCETAXEL | 02 | null | 20079672 | FEC + DOCETAXEL |
| 20022611 | 20009604 | 1.73 | 71.1 | Curative (C) | 2014-02-05 | 2014-02-06 | FEC + DOCETAXEL | 2 | N | 20079672 | FEC + DOCETAXEL |
| 20022612 | 20009604 | 1.7 | 10 | Adjuvant (A) | 2013-05-25 | 2013-06-07 | FEC + DOCETAXEL | 2 | N | 20079672 | FEC + DOCETAXEL |
| 20022613 | 20009605 | 1.52 | null | Adjuvant (A) | 2015-02-17 | 2015-03-03 | FEC + DOCETAXEL | 2 | null | 20079684 | FEC + DOCETAXEL |
| 20022614 | 20070474 | 1.71 | 82.6 | Adjuvant (A) | 2016-04-07 | 2016-04-08 | FEC + DOCETAXEL | 02 | N | 20079690 | FEC + DOCETAXEL |
| 20022615 | 20009606 | 1.61 | 71 | Curative (C) | 2014-05-05 | 2014-05-09 | FEC + DOCETAXEL | 02 | null | 20079693 | FEC + DOCETAXEL |
| 20022616 | 20070475 | 1.67 | 63 | Adjuvant (A) | 2015-03-30 | 2015-04-19 | FEC + DOCETAXEL | N | N | 20079694 | FEC + DOCETAXEL |
| 20022617 | 20009607 | 1.68 | 77.7 | Adjuvant (A) | null | 2013-07-26 | FEC 100 + DOCETAXEL | N | N | 20079700 | FEC + DOCETAXEL |
| 20022618 | 20009607 | 1.67 | 55.4 | Adjuvant (A) | 2016-08-03 | 2016-08-05 | FEC + DOCETAXEL | 02 | N | 20079700 | FEC + DOCETAXEL |
| 20022619 | 20009608 | 1.68 | 56.2 | Adjuvant (A) | 2016-10-26 | 2016-11-25 | FEC + DOCETAXEL | 2 | N | 20079708 | FEC + DOCETAXEL |
| 20022620 | 20009609 | 1.63 | 95.45 | Not known (9) | 2017-04-11 | 2017-04-16 | FEC + DOCETAXEL | 2 | N | 20079711 | FEC + DOCETAXEL |
| 20022621 | 20009609 | 1.68 | 72.6 | Adjuvant (A) | 2015-12-07 | 2015-12-12 | FEC + DOCETAXEL | 02 | N | 20079711 | FEC + DOCETAXEL |
| 20022622 | 20009609 | 0 | 49.4 | Adjuvant (A) | 2013-11-25 | 2013-12-10 | FEC + DOCETAXEL | 02 | Y | 20079711 | FEC + DOCETAXEL |
| 20022623 | 20009609 | null | null | null | 2013-11-05 | 2013-12-08 | FEC + DOCETAXEL | 2 | N | 20079711 | FEC + DOCETAXEL |
| 20022624 | 20009609 | 1.5 | 94.1 | Adjuvant (A) | 2016-08-03 | 2016-08-16 | FEC 100 + DOCETAXEL | 2 | N | 20079711 | FEC + DOCETAXEL |
| 20022625 | 20009610 | 1.63 | 66 | Curative (C) | null | 2015-03-26 | FEC + DOCETAXEL | N | N | 20079725 | FEC + DOCETAXEL |
| 20022626 | 20009610 | 1.67 | 66 | Adjuvant (A) | 2014-10-21 | 2014-10-24 | FEC + DOCETAXEL | 2 | N | 20079725 | FEC + DOCETAXEL |
| 20022627 | 20009611 | 1.54 | 78.3 | Curative (C) | 2018-02-12 | 2018-03-05 | FEC 100 + DOCETAXEL | 02 | N | 20079727 | FEC + DOCETAXEL |
| 20022628 | 20009612 | 1.62 | 63.7 | Curative (C) | 2013-05-10 | 2013-05-29 | FEC + DOCETAXEL | 02 | N | 20079732 | FEC + DOCETAXEL |
| 20022629 | 20009613 | 1.62 | 66 | Not known (9) | 2015-11-24 | 2015-12-25 | FEC 100 + DOCETAXEL | N | N | 20079737 | FEC + DOCETAXEL |
| 20022630 | 20009613 | 0 | 51.4 | Neo-adjuvant (N) | 2015-04-29 | 2015-04-29 | FEC + DOCETAXEL | 2 | N | 20079737 | FEC + DOCETAXEL |
| 20022631 | 20108206 | 1.68 | 88 | Neo-adjuvant (N) | 2017-01-25 | 2017-01-25 | FEC 100 + DOCETAXEL | 02 | N | 20079744 | FEC + DOCETAXEL |
| 20022632 | 20108206 | null | null | Adjuvant (A) | 2017-09-11 | 2017-09-25 | FEC + DOCETAXEL | null | null | 20079744 | FEC + DOCETAXEL |
| 20022633 | 20108206 | 1.69 | 89.75 | Adjuvant (A) | 2014-09-09 | 2014-10-01 | FEC + DOCETAXEL | 02 | N | 20079744 | FEC + DOCETAXEL |
| 20022634 | 20143056 | 1.64 | 10 | Adjuvant (A) | 2013-07-18 | 2013-07-25 | FEC + DOCETAXEL | 02 | N | 20079754 | FEC + DOCETAXEL |
| 20022635 | 20143056 | 1.73 | 66.4 | Adjuvant (A) | 2015-07-26 | 2015-08-18 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20079754 | FEC + DOCETAXEL |
| 20022636 | 20143056 | 1.61 | 55.8 | Adjuvant (A) | 2015-10-08 | 2015-10-29 | FEC 100 + DOCETAXEL | N | N | 20079754 | FEC + DOCETAXEL |